Your session is about to expire
← Back to Search
Axitinib for Kidney Cancer
Study Summary
This trial will study whether axitinib can help control kidney cancer, as well as the drug's safety.
- Kidney Cancer
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2019 Phase 2 trial • 13 Patients • NCT02129647Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: Axitinib
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How does Axitinib compare to similar treatments in terms of risk?
"With data suggesting Axitinib's safety but not its efficacy, it is given a rating of 2."
Is this clinical trial unique in its design and scope?
"Axitinib has been subject to a decade of scientific scrutiny, beginning with the Pfizer-sponsored study in 2011 involving 39 patients. Following this preliminary research and approval at Phase 2 level, Axitinib is now under investigation by 48 separate clinical trials across 30 nations worldwide."
Are there any precedents of Axitinib being used in clinical research?
"At the present moment, 48 clinical trials concerning Axitinib are underway. Of these studies, 4 have reached Phase 3 of development. Although Houston is leading the way in this investigational research with numerous sites enrolled in such initiatives, there are 1038 other locations around the world that host such trials as well."
How many individuals are taking part in this clinical research project?
"This clinical trial has ceased participant recruitment. It was initially posted on February 1st 2011 but its last update occurred on September 2nd 2022. If you are in search of other studies, presently there are 2641 trials for renal cancer and 48 trials for Axitinib seeking participants."
Are there any vacancies available to join this experiment?
"Unfortunately, this medical trial has closed recruitment. It was published on February 1st 2011 and the last update occurred September 2nd 2022. If you are in search of other clinical research opportunities, 2641 studies involving renal cancers and 48 trials using Axitinib are currently searching for participants."
Share this study with friends
Copy Link
Messenger